| Breakdown | TTM | Feb 2025 | Feb 2024 | Feb 2023 | Nov 2021 | Nov 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 84.98B | 83.38B | 80.36B | 74.52B | 73.13B | 73.03B |
| Gross Profit | 31.64B | 30.54B | 28.53B | 26.82B | 26.70B | 26.80B |
| EBITDA | 2.88B | 1.99B | 1.33B | 1.63B | 2.25B | 2.76B |
| Net Income | 805.00M | -163.00M | -1.17B | -274.40M | 194.00M | 440.00M |
Balance Sheet | ||||||
| Total Assets | 34.24B | 29.64B | 29.34B | 28.44B | 28.29B | 28.64B |
| Cash, Cash Equivalents and Short-Term Investments | 5.13B | 2.03B | 2.83B | 3.95B | 3.16B | 4.28B |
| Total Debt | 3.90B | 3.90B | 3.80B | 803.00M | 17.00M | 0.00 |
| Total Liabilities | 23.32B | 19.22B | 18.66B | 16.34B | 15.77B | 16.06B |
| Stockholders Equity | 10.91B | 10.42B | 10.68B | 12.10B | 12.52B | 12.57B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 36.00M | -2.44B | -288.00M | -664.00M | 638.00M |
| Operating Cash Flow | 0.00 | 1.89B | -899.00M | 906.00M | 1.17B | 2.06B |
| Investing Cash Flow | 0.00 | -2.51B | -2.11B | -1.54B | -2.02B | -1.70B |
| Financing Cash Flow | 0.00 | -173.00M | 2.72B | 519.00M | -272.00M | -271.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
66 Neutral | ¥636.20B | 22.09 | 7.58% | 2.58% | 6.52% | -31.67% | |
66 Neutral | ¥282.15B | 2.68 | 4.97% | 2.01% | 2.00% | -68.35% | |
63 Neutral | ¥216.74B | 17.32 | ― | 3.01% | 18.89% | -34.43% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
58 Neutral | ¥5.36T | -128.08 | 2.27% | 0.52% | 4.92% | 1.25% | |
53 Neutral | ¥51.78B | -5.76 | ― | 0.94% | 10.66% | -218.40% | |
48 Neutral | ¥51.56B | 90.62 | ― | 0.51% | 2.90% | ― |